Sravani Lokineni

Sravani Lokineni practices at Deaconess Midtown Hospital - Outpatient Therapy in Evansville, Indiana.

Sravani Lokineni's NPI, 1962063081, was assigned on June 28, 2019. Sravani Lokineni holds Kentucky license 58710.

Sravani Lokineni's primary practice is Deaconess Midtown Hospital - Outpatient Therapy, at 600 Mary St, Evansville, IN 47747. The practice phone is (812) 450-3324.

Sravani Lokineni's primary practice is Deaconess Midtown Hospital - Outpatient Therapy in Evansville, Indiana. Sravani Lokineni is also affiliated with Deaconess Midtown Hospital. The medical group on file is Deaconess Health System. Dmand AI also links Sravani Lokineni to 4 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Sravani Lokineni practices, 8 sites in all. Vendor and product names are available with a free account.

Rheumatology is Sravani Lokineni's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Sravani Lokineni is licensed in Kentucky.

CMS data shows 79 Medicare services from Sravani Lokineni across 4 procedure codes in 2024, all of them office visits, for 51 Medicare patients. Medicare paid $10,377 for them. Every service was in an office.

CMS counts 51 Medicare patients who saw Sravani Lokineni in 2024. The largest group is 65 to 74, with 29 patients. 75% of them have arthritis, and 75% have high blood pressure. Their average risk score is 1.02, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Sravani Lokineni's median patient age at 68, with 70% women.

In 2024, Sravani Lokineni wrote 557 Medicare Part D claims for 120 patients. 93% of them were for generic drugs. CMS names the drug for 428 of them, across 13 drugs with 11 or more claims each, at $99,537 in total drug cost. In 2023, CMS named 127 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Sravani Lokineni for performance year 2024, reported as part of a group. Sravani Lokineni accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Sravani Lokineni as offering telehealth.

Dmand AI links 10 papers to Sravani Lokineni, published from 2021 to 2022. 2021 was the busiest year, with 8. Sravani Lokineni has published most often in Eur J Case Rep Intern Med. Sravani Lokineni's most frequent co-authors are Megha E. Garg, MD, Mahta Mortezavi, MD and Mahesh Nepal, MD.

CMS Open Payments shows 57 general payments to Sravani Lokineni from 14 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 92% of the total. Abbvie Inc. paid the most, $394.